US cuts $1.95 billion deal with Pfizer for 100 million doses of COVID-19 vaccine
Published
Pfizer and BioNTech announced a $1.95 billion deal with the United States for pre-purchase of 100 million doses of an experimental vaccine candidate.
Published
Pfizer and BioNTech announced a $1.95 billion deal with the United States for pre-purchase of 100 million doses of an experimental vaccine candidate.
LONDON (AP) — Pharma giants GlaxoSmithKline and Sanofi Pasteur have announced they will supply 100 million doses of an..
By Matt Hadro
As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the..